# Does Vitamin D Supplementation Impact Fibromyalgia-Related Pain? A Systematic Review and Meta-Analysis

**Authors:** Sara Ilari, Saverio Nucera, Valentina Malafoglia, Stefania Proietti, Lucia Carmela Passacatini, Rosamaria Caminiti, Valeria Mazza, Alessia Bonaddio, Francesca Oppedisano, Jessica Maiuolo, Daniela Caccamo, Marco Tafani, Carlo Tomino, Vincenzo Mollace, William Raffaeli, Carolina Muscoli

PMC · DOI: 10.3390/nu17203232 · Nutrients · 2025-10-15

## TL;DR

This study finds that vitamin D supplementation may help reduce pain and improve quality of life for people with fibromyalgia.

## Contribution

The study provides a meta-analysis showing vitamin D's potential as an adjunct treatment for fibromyalgia-related pain.

## Key findings

- Vitamin D supplementation significantly reduced pain levels compared to the control group.
- Improvement in quality of life was observed with vitamin D supplementation.
- Statistically significant effects were found using NRS/VAS and FIQ scales.

## Abstract

Background: Fibromyalgia is a chronic condition characterized by widespread pain, fatigue, and localized tenderness. Its pathophysiology remains unclear, and treatment options are often limited and only partially effective. Recent studies suggest a potential link between vitamin D deficiency and symptom severity, as vitamin D may play a role in modulating pain and inflammation. Methods: This systematic review and meta-analysis assessed the efficacy of vitamin D supplementation in reducing pain and improving quality of life in fibromyalgia patients, focusing on studies up to 31 December 2024. Following PRISMA guidelines, a literature search in PubMed, Web of Science, and Scopus identified 2776 articles; 7 were included in the systematic review and 4 studies in each meta-analysis. Results: Results showed that vitamin D supplementation significantly reduced pain levels compared to the control group, with a statistically significant effect observed using the NRS or VAS (SMD = −0.85; 95% CI: −1.54 to −0.17; p = 0.0148), as well as the FIQ scale (SMD = −0.87; 95% CI: −1.56 to −0.20; p= 0.0115), resulting in an improvement in quality of life. Conclusions: These findings suggest that vitamin D may be a valuable adjunct in fibromyalgia management, particularly for pain. However, further high-quality trials are needed to confirm these effects and identify responsive patient subgroups.

## Linked entities

- **Diseases:** fibromyalgia (MONDO:0005546)

## Full-text entities

- **Diseases:** fatigue (MESH:D005221), inflammation (MESH:D007249), Fibromyalgia (MESH:D005356), Pain (MESH:D010146), tenderness (MESH:D063806)
- **Chemicals:** Vitamin D (MESH:D014807)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12567182/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12567182/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC12567182/full.md

---
Source: https://tomesphere.com/paper/PMC12567182